Rowena Fernandez Choudrie,Willard Foss,Che-Hsiung Hsu,Amol Mungikar,Yu Pu
申请号：
US16730591
公开号：
US20200206212A1
申请日:
2019.12.30
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are formulations and methods of use of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide or a stereoisomer or mixture of stereoisomers, pharmaceutically acceptable salt, tautomer, prodrug, isotopologue, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.
